Artificial intelligence allows underserved populations to gain access to a radiologist, pointed out Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine.
Artificial intelligence allows underserved populations to gain access to a radiologist by just clicking a snapshot on their cell phone, said Anthony L. Loschner, MD, assistant professor and associate program director, Critical Care Fellowship Program, Virginia Tech Carilion School of Medicine, about his presentation at this year’s CHEST meeting.
Transcript
Introduce us to the use of artificial intelligence in pulmonary medicine.
The title of my presentation was “Artificial Intelligence in Pulmonary Medicine: The Rise of the Machines." And we reviewed the major articles that had been published in the last year or so guiding future AI in pulmonary medicine.
There were some reviews that were done, literature reviews, where I reviewed articles on how AI is currently being used. Examples include great work by a Stanford team called ChestNet, and they're using a deep learning algorithm to read chest x-rays on any media pretty much. So you point your cell phone at a chest x- ray, take a picture, upload it, and their AI system can read it pretty accurately for the 14 most common diseases found on chest x-rays.
That's important because it can allow access to care. Radiologists are far in-between, so this allows underserved populations to gain access to a radiologist by just clicking a snapshot on their cell phone and uploading it.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More